Finance

Lists
Why is 4884 down 5.91%?
Dive Deeper
4884:TYO
Kringle Pharma Inc
Â¥541.00
-5.91%
(-34.00) 1D
Nov 20, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4884...
Open
Â¥546
High
Â¥563
Low
Â¥502
Mkt. cap
4.65B
Avg. vol.
429.40K
Volume
543.00K
52-wk high
Â¥741
52-wk low
Â¥287
EPS
-Â¥111
No. of employees
17
Open
Â¥546
High
Â¥563
Low
Â¥502
Mkt. cap
4.65B
Avg. vol.
429.40K
Volume
543.00K
52-wk high
Â¥741
52-wk low
Â¥287
EPS
-Â¥111
No. of employees
17
News stories
From web sources and news partners
About Kringle Pharma Inc
CEOKiichi Adachi
Employees17
FoundedDec 21, 2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
18.57M
17.43M
287.15M
118.11M
Cost of goods sold
-
-
70.39M
614.00K
Cost of revenue
-
-
70.39M
614.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
218.48M
333.52M
335.44M
297.55M
Operating expense
218.48M
333.52M
335.44M
297.55M
Total operating expenses
218.48M
333.52M
405.83M
298.16M
Operating income
-199.91M
-316.09M
-118.67M
-180.05M
Other non operating income
38.00K
962.00K
1.40M
1.59M
EBT including unusual items
-201.48M
-313.52M
-114.70M
-181.72M
EBT excluding unusual items
-200.05M
-313.95M
-114.70M
-182.52M
Income tax expense
372.00K
628.00K
372.00K
-388.00K
Effective tax rate
-0.18%
-0.20%
-0.32%
0.21%
Other operating expenses
-
-
-
-
Net income
-201.85M
-314.15M
-115.08M
-181.33M
Net profit margin
-1,086.97%
-1,802.35%
-40.07%
-153.52%
Earnings per share
-
-
-
-
Interest and investment income
-
1.00M
-
-
Interest expense
-
-
-
-893.00K
Net interest expenses
-
1.00M
-
-893.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps